• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles The pharmacy is proud to be community focused and patient centered. Read More

Streamlining Pain Management: Shore Medical Center’s Pharmacist-Driven Opioid Conversion Initiative

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Shore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management. Read More

Daratumumab and missed sequencing opportunities in transplant-ineligible multiple myeloma: lessons for future trials

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Streamlining the Route of Administration of Monoclonal Antibody Therapies for Better Patient Outcomes in the NSCLC Population

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles A panelist discusses how the PALOMA-3 study demonstrated that subcutaneous amivantamab is noninferior to intravenous (IV) administration with significantly lower infusion-related reaction (IRR) rates (13% vs 66%), shorter administration...

Steroid-Refractory cGVHD: A Look at FDA-Approved Options

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Panelists discuss how recent FDA approvals and evolving evidence for second-line treatments, including ruxolitinib, ibrutinib, and belumosudil, are reshaping chronic graft-vs-host disease (cGVHD) management by offering tailored,...

Tailoring Therapy: Weighing Evidence, Organ Involvement, and Route of Administration

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Panelists discuss how factors such as patient preferences, disease severity, organ-specific involvement, and adverse effect profiles influence the selection of second-line therapies for steroid-refractory chronic graft-vs-host disease...
« Older Entries
Next Entries »

Recent Content

  • Ambulatory Pharmacy in Action: House Calls and Harm Reduction Clinics Expand the Reach of Care
  • Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer
  • Reimagining Pain Management: Pharmacists Urged to “Deconstruct the Cupcake”
  • Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
  • Targeted Chemo Improves Survival in Early-Stage Lung Cancer
  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT